COVID-19 Today’s Facts!
What's about COVID-19?
Frequently Asked Questions
What is COVID-19?
COVID-19 is the disease caused by a new coronavirus called SARS-CoV-2. WHO first learned of this new virus on 31 December 2019, following a report of a cluster of cases of ‘viral pneumonia’ in Wuhan, People’s Republic of China.
What are the symptoms of COVID-19?
The most common symptoms of COVID-19 are
- Fever
- Dry cough
- Fatigue
Other symptoms that are less common and may affect some patients include:
- Loss of taste or smell,
- Nasal congestion,
- Conjunctivitis (also known as red eyes)
- Sore throat,
- Headache,
- Muscle or joint pain,
- Different types of skin rash,
- Nausea or vomiting,
- Diarrhea,
- Chills or dizziness.
Symptoms of severe COVID‐19 disease include:
- Shortness of breath,
- Loss of appetite,
- Confusion,
- Persistent pain or pressure in the chest,
- High temperature (above 38 °C).
Other less common symptoms are:
- Irritability,
- Confusion,
- Reduced consciousness (sometimes associated with seizures),
- Anxiety,
- Depression,
- Sleep disorders,
- More severe and rare neurological complications such as strokes, brain inflammation, delirium and nerve damage.
People of all ages who experience fever and/or cough associated with difficulty breathing or shortness of breath, chest pain or pressure, or loss of speech or movement should seek medical care immediately. If possible, call your health care provider, hotline or health facility first, so you can be directed to the right clinic.
What happens to people who get COVID-19?
Among those who develop symptoms, most (about 80%) recover from the disease without needing hospital treatment. About 15% become seriously ill and require oxygen and 5% become critically ill and need intensive care.
Complications leading to death may include respiratory failure, acute respiratory distress syndrome (ARDS), sepsis and septic shock, thromboembolism, and/or multiorgan failure, including injury of the heart, liver or kidneys.
In rare situations, children can develop a severe inflammatory syndrome a few weeks after infection.
Who is most at risk of severe illness from COVID-19?
However, anyone can get sick with COVID-19 and become seriously ill or die at any age
Are there long-term effects of COVID-19?
WHO is working with our Global Technical Network for Clinical Management of COVID-19, researchers and patient groups around the world to design and carry out studies of patients beyond the initial acute course of illness to understand the proportion of patients who have long term effects, how long they persist, and why they occur. These studies will be used to develop further guidance for patient care.
How can we protect others and ourselves if we don't know who is infected?
When should I get a test for COVID-19?
While a person is waiting for test results, they should remain isolated from others. Where testing capacity is limited, tests should first be done for those at higher risk of infection, such as health workers, and those at higher risk of severe illness such as older people, especially those living in seniors’ residences or long-term care facilities.
What test should I get to see if I have COVID-19?
What about rapid tests?
I want to find out if I had COVID-19 in the past, what test could I take?
What is the difference between isolation and quarantine?
Both isolation and quarantine are methods of preventing the spread of COVID-19.
Quarantine is used for anyone who is a contact of someone infected with the SARS-CoV-2 virus, which causes COVID-19, whether the infected person has symptoms or not. Quarantine means that you remain separated from others because you have been exposed to the virus and you may be infected and can take place in a designated facility or at home. For COVID-19, this means staying in the facility or at home for 14 days.
Isolation is used for people with COVID-19 symptoms or who have tested positive for the virus. Being in isolation means being separated from other people, ideally in a medically facility where you can receive clinical care. If isolation in a medical facility is not possible and you are not in a high risk group of developing severe disease, isolation can take place at home. If you have symptoms, you should remain in isolation for at least 10 days plus an additional 3 days without symptoms. If you are infected and do not develop symptoms, you should remain in isolation for 10 days from the time you test positive.
What should I do if I have been exposed to someone who has COVID-19?
If you have been exposed to someone with COVID-19, you may become infected, even if you feel well.
After exposure to someone who has COVID-19, do the following:
- Call your health care provider or COVID-19 hotline to find out where and when to get a test.
- Cooperate with contact-tracing procedures to stop the spread of the virus.
- If testing is not available, stay home and away from others for 14 days.
- While you are in quarantine, do not go to work, to school or to public places. Ask someone to bring you supplies.
- Keep at least a 1-metre distance from others, even from your family members.
- Wear a medical mask to protect others, including if/when you need to seek medical care.
- Clean your hands frequently.
- Stay in a separate room from other family members, and if not possible, wear a medical mask.
- Keep the room well-ventilated.
- If you share a room, place beds at least 1 metre apart.
- Monitor yourself for any symptoms for 14 days.
- Stay positive by keeping in touch with loved ones by phone or online, and by exercising at home.
If you live in an area with malaria or dengue fever, seek medical help if you have a fever. While travelling to and from the health facility and during medical care, wear a mask, keep at least a 1-metre distance from other people and avoid touching surfaces with your hands. This applies to adults and children.
How long does it take to develop symptoms?
What should I do if I have COVID-19 symptoms?
If you have shortness of breath or pain or pressure in the chest, seek medical attention at a health facility immediately. Call your health care provider or hotline in advance for direction to the right health facility.
If you live in an area with malaria or dengue fever, seek medical care if you have a fever.
If local guidance recommends visiting a medical centre for testing, assessment or isolation, wear a medical mask while travelling to and from the facility and during medical care. Also keep at least a 1-metre distance from other people and avoid touching surfaces with your hands. This applies to adults and children.
Are there treatments for COVID-19?
Scientists around the world are working to find and develop treatments for COVID-19.
Optimal supportive care includes oxygen for severely ill patients and those who are at risk for severe disease and more advanced respiratory support such as ventilation for patients who are critically ill.
Dexamethasone is a corticosteroid that can help reduce the length of time on a ventilator and save lives of patients with severe and critical illness.
Results from the WHO’s Solidarity Trial indicated that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appear to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.
Hydroxychloroquine has not been shown to offer any benefit for treatment of COVID-19.
WHO does not recommend self-medication with any medicines, including antibiotics, as a prevention or cure for COVID-19. WHO is coordinating efforts to develop treatments for COVID-19 and will continue to provide new information as it becomes available.
Are antibiotics effective in preventing or treating COVID-19?
In hospitals, physicians will sometimes use antibiotics to prevent or treat secondary bacterial infections which can be a complication of COVID-19 in severely ill patients. They should only be used as directed by a physician to treat a bacterial infection.
Source text : who.int
COVIGEN Project, needle-free SARS-CoV-2 Recombinant DNA vaccine
The future control of SARS-CoV-2 depends on the availability of one or more reliable and immunogenic vaccines. National and international initiatives are being implemented on an unprecedented scale to develop safe and effective vaccines.
Our “COVIGEN project” was selected by the Medical Research Future Fund (MRFF) to be evaluated for a clinical trial in Australia. (source: Australia’s first COVID-19 vaccine study to begin)